Jean-Yves Blay

Jean-Yves Blay

UNVERIFIED PROFILE

Are you Jean-Yves Blay?   Register this Author

Register author
Jean-Yves Blay

Jean-Yves Blay

Publications by authors named "Jean-Yves Blay"

Are you Jean-Yves Blay?   Register this Author

100Publications

2897Reads

26Profile Views

The Oncology Data Network (ODN): A Collaborative European Data-Sharing Platform to Inform Cancer Care.

Oncologist 2019 Sep 5. Epub 2019 Sep 5.

Center for Oncological Research (CORE), University of Antwerp, and Antwerp University Hospital, Edegem, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0337DOI Listing
September 2019

Treatment of advanced soft tissue sarcoma by histological subtype: wish, prediction or reality?

Authors:
Jean-Yves Blay

Future Oncol 2019 Sep 10. Epub 2019 Sep 10.

Department of Medical Oncology, Centre Léon Bérard, Université Claude Bernard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0488DOI Listing
September 2019

Successful Treatment of Metastatic Adult Wilms Tumor With Anti-BRAF Treatment: A Case Report and a Brief Review of the Literature.

Clin Genitourin Cancer 2019 Aug 15;17(4):e721-e723. Epub 2019 Mar 15.

Department of Medical Oncology, Saint-André Hospital, Bordeaux University Hospital, Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.02.012DOI Listing
August 2019

Local Control and Analgesic Efficacy of Percutaneous Cryoablation for Desmoid Tumors.

Cardiovasc Intervent Radiol 2019 Aug 30. Epub 2019 Aug 30.

Department of Interventional Radiology, Centre Léon Bérard, 28 Prom. Léa Et Napoléon Bullukian, 69008, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00270-019-02323-5DOI Listing
August 2019

Editorial: Customizing sarcoma management and treatment.

Authors:
Jean-Yves Blay

Curr Opin Oncol 2019 Jul;31(4):302-303

Department of Medical Oncology, Centre Léon Bérard.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000551DOI Listing
July 2019

PARP1 expression in soft tissue sarcomas is a poor-prognosis factor and a new potential therapeutic target.

Mol Oncol 2019 Jul 7;13(7):1577-1588. Epub 2019 Jun 7.

Predictive Oncology Laboratory, Marseille Cancer Research Center (CRCM), Institut Paoli-Calmettes, U1068 INSERM, U7258 CNRS, Aix-Marseille University, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/1878-0261.12522DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599836PMC
July 2019

Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas.

Mod Pathol 2019 Jul 1. Epub 2019 Jul 1.

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0312-yDOI Listing
July 2019

Recurrent DMD Deletions Highlight Specific Role of Dp71 Isoform in Soft-Tissue Sarcomas.

Cancers (Basel) 2019 Jul 1;11(7). Epub 2019 Jul 1.

Institut national de la santé et de la recherche médicale (INSERM) U1218, Bergonié Cancer Institute, F-33076 Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11070922DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678178PMC
July 2019

Personalised management of alveolar soft part sarcoma: a promising phase 2 study.

Lancet Oncol 2019 Jun 8;20(6):750-752. Epub 2019 May 8.

Department of Medical Oncology and University Claude Bernard, Léon Bérard Cancer Center, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30286-4DOI Listing
June 2019

From rare to well-done: importance of rare tumors in cancer therapeutic advances.

Oncotarget 2019 Jun 18;10(40):3998-3999. Epub 2019 Jun 18.

Oncology Medical Unit, CHU La Timone and Aix-Marseille University, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592290PMC
June 2019

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

J Immunother Cancer 2019 Mar 28;7(1):85. Epub 2019 Mar 28.

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Cancer Research Center of Lyon (CRCL), Centre Léon Bérard, F-69008, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-019-0549-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437964PMC
March 2019

Patterns of Care and Outcome Radiation-Induced Soft Tissue Sarcomas.

Int J Radiat Oncol Biol Phys 2019 02 5;103(2):449-452. Epub 2018 Oct 5.

Department of Radiation Oncology, Sorbonne University, HU La Pitié Salpêtrière Charles Foix, Assistance-Publique des Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016183380
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2018.09.028DOI Listing
February 2019

[Precision medicine in oncology: Challenges, stakes and new paradigms].

Bull Cancer 2019 Feb 1;106(2):97-104. Epub 2019 Feb 1.

Institut Roche for research & translational medicine, 30, cours de l'île-Seguin, 92650 Boulogne-Billancourt, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2019.01.007DOI Listing
February 2019

Networking in rare cancers: What was done, what's next.

Eur J Surg Oncol 2019 01 12;45(1):16-18. Epub 2018 Apr 12.

Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Via G. Venezian 1, 20133, Milan, Italy; Department of Medical Oncology and Haemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2018.03.030DOI Listing
January 2019

International Collaborations and Regional Challenges in Providing Specialist Multidisciplinary Sarcoma Care.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:616-623. Epub 2019 May 17.

3 Oncology Center, Hospital Sírio Libanês, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_239131DOI Listing
January 2019

Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study.

J Clin Oncol 2018 Oct 5:JCO1800454. Epub 2018 Oct 5.

Martee L. Hensley, Memorial Sloan Kettering Cancer Center; Martee L. Hensley and Oliver Zivanovic, Weill Cornell Medical College, New York City; Danielle Enserro and Shashikant B. Lele, Roswell Park Comprehensive Cancer Center, Buffalo, NY; Helen Hatcher, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge; Cyril Fisher, University of Birmingham, Birmingham, United Kingdom; Petronella B. Ottevanger, Radboud University Medical Center, Nijmegen, the Netherlands; Anders Krarup-Hansen, University Hospital Copenhagen, Copenhagen, Denmark; Jean-Yves Blay, Centre Leon Berard, Lyon, France; Katherine M. Moxley, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Jayanthi S. Lea, and David S. Miller, The University of Texas Southwestern Medical Center, Dallas, TX; Krishnansu S. Tewari, University of California at Irvine, Orange, CA; Premal H. Thaker, Washington University School of Medicine, and Siteman Cancer Center, St Louis, MO; David M. O'Malley, The Ohio State University College of Medicine, Columbus, OH; Katina Robison, Women and Infants Hospital in Rhode Island, Providence, RI.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.00454
Publisher Site
http://dx.doi.org/10.1200/JCO.18.00454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241678PMC
October 2018

BRAF Inhibition in BRAF-Mutant Gliomas: Results From the VE-BASKET Study.

J Clin Oncol 2018 Oct 23:JCO2018789990. Epub 2018 Oct 23.

Thomas Kaley, Lisa M. DeAngelis, Jose Baselga, and David M. Hyman, Memorial Sloan Kettering Cancer Center; Thomas Kaley, Lisa M. DeAngelis, Jose Baselga, and David M. Hyman, Weill Cornell Medical College, New York; Igor Puzanov, Roswell Park Cancer Institute, Buffalo, NY; Mehdi Touat and Antoine Hollebecque, Institut Gustave Roussy, Villejuif; Franck Bielle, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris; Florence Joly, Centre François Baclesse, Caen; Jean-Yves Blay, Centre Léon Bérard, Lyon, France; Vivek Subbiah, MD Anderson Cancer Center, Houston, TX; Jordi Rodon, Vall d'Hebron University Hospital, Barcelona, Spain; A. Craig Lockhart, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; Vicki Keedy, Vanderbilt University Medical Center, Nashville, TN; Ralf-Dieter Hofheinz, Universitätsmedizin Mannheim, Mannheim; Jurgen Wolf, Universitätsklinikum Köln, Cologne, Germany; Ian Chau, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom; Noopur S. Raje, Massachusetts General Hospital, Boston, MA; Martina Makrutzki, F Hoffmann-La Roche, Basel, Switzerland; Todd Riehl, Genentech, South San Francisco, CA; and Bethany Pitcher, F Hoffmann-La Roche, Mississauga, Ontario, Canada.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.9990
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.9990DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286161PMC
October 2018

High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008.

J Clin Oncol 2018 Sep 6:JCO2018782516. Epub 2018 Sep 6.

Jeremy Whelan, University College Hospital; Ian Judson, Institute of Cancer Research, London; Bernadette Brennan, Royal Manchester Children's Hospital, Manchester; Bruce Morland, Birmingham Children's Hospital; Keith Wheatley, University of Birmingham, Birmingham; Ian Lewis, Leeds Community Healthcare National Health Service Trust, Leeds; Alan Craft, Newcastle University, Newcastle upon Tyne, United Kingdom; Marie-Cecile Le Deley and Cyril Lervat, Centre Oscar Lambret, Lille; Gwénaël Le Teuff, Nathalie Gaspar, and Odile Oberlin, Institut Gustave Roussy, Villejuif; Jean-Yves Blay, Centre Léon Bérard; Perrine Marec-Berard, Institute of Pediatric Onco-Haematology, Lyon; Marie-Pierre Castex, Centre Hospitalier Universitaire de Toulouse, Toulouse; Jean-Claude Gentet, Centre Hospitalier Universitaire La Timone, Marseille; Marta Jimenez, Unicancer; Valerie Laurence and Jean Michon, Institut Curie, Paris; France; Uta Dirksen, Sebastian Bauer, Andreas Ranft, University Hospital Essen, Essen; Susanne Amler, Institut für Biometrie und Klinische Forschung; Wolfgang Hartmann and Heribert Juergens, Universitätsklinikum, Münster, Münster; Stefan Bielack, Klinikum Stuttgart, Stuttgart; Stefan Burdach, Comprehensive Cancer Center, München; Dagmar Dilloo, University-Clinic Bonn, Bonn; Angelika Eggert, Charité University; Peter Reichardt, HELIOS Klinikum Berlin-Buch, Berlin; Wolf-Achim Hassenpflug, University Medical Center Hamburg-Eppendorf, Hamburg; Thomas Klingebiel, Childrens University Hospital, Frankfurt; Udo Kontny, University Medical Center Aachen, Aachen; Michael Paulussen, Children's and Adolescents' Hospital, Datteln; Germany; Douglas S. Hawkins, Seattle Children's Hospital, Seattle, WA; Hans Gelderblom, Leiden University Medical Center, Leiden; Hendrik van den Berg, University of Amsterdam, Amsterdam, the Netherlands; Lars Hjorth, Skane University Hospital, Lund, Sweden; Jarmila Kruseova, Faculty Hospital Motol Prague, Prague, Czech Republic; Ruth Ladenstein, St Anna Children's Hospital and Children's Cancer Research Institute, Vienna, Austria; Sandrine Marreaud, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.2516
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.2516DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209090PMC
September 2018

Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma.

Eur J Cancer 2018 08 11;99:28-36. Epub 2018 Jun 11.

Department of Clinical Research and Innovation, Centre Oscar Lambret, 3 rue Combemale, 59000 Lille, France; Paris-Saclay University, Univ. Paris-Sud, CESP, INSERM, Gustave Roussy, 94805 Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.05.008DOI Listing
August 2018

Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumours.

Nat Rev Clin Oncol 2018 07;15(7):443-458

Department of Medical Oncology, Centre Leon Berard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-018-0012-4DOI Listing
July 2018

Management of sarcoma patients: centralization in reference centers to fragmentation of systemic treatment.

Authors:
Jean-Yves Blay

Curr Opin Oncol 2018 07;30(4):240-242

Centre Léon Bérard, Université Claude Bernard, Lyon, France.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00001622-900000000-9925
Publisher Site
http://dx.doi.org/10.1097/CCO.0000000000000461DOI Listing
July 2018

Beliefs and behavior regarding e-cigarettes in a large cross-sectional survey.

Prev Med Rep 2018 Jun 18;10:332-336. Epub 2018 Apr 18.

Aix Marseille University, Assistance Publique-Hôpitaux de Marseille, Department of Multidisciplinary Oncology and Therapeutic Innovations, Chemin des Bourrely, 13915 Marseille Cedex 20, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pmedr.2018.04.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984220PMC
June 2018

Getting up-to-date in the management of soft tissue sarcoma.

Authors:
Jean-Yves Blay

Future Oncol 2018 May;14(10s):3-13

Department of Medical Oncology, Centre Leon Berard and University Claude Bernard Lyon I, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0074DOI Listing
May 2018

Gastrointestinal stromal tumors (GIST) presenting in the liver: Diagnostic, prognostic and therapeutic issues.

Clin Res Hepatol Gastroenterol 2018 04 20;42(2):e23-e28. Epub 2017 Jun 20.

Département de Biologie et Pathologie Médicales, Gustave-Roussy Cancer Campus, 94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinre.2017.05.010DOI Listing
April 2018

Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine.

J Clin Oncol 2017 Oct 30;35(30):3433-3439. Epub 2017 Aug 30.

George D. Demetri, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Patrick Schöffski, University Hospitals Leuven, Leuven, Belgium; Giovanni Grignani, Fondazione del Piemonte per l'Oncologia Istituto di Ricovero e Cura a Carattere Scientifico, Candiolo, Italy; Jean-Yves Blay, Université Claude Bernard and Centre Léon Bérard, Lyon, France; Robert G. Maki, Monter Cancer Center, Lake Success; and Cold Spring Harbor Laboratory, New Hyde Park, NY; Brian A. Van Tine, Barnes and Jewish Hospital, Washington University in St. Louis, St. Louis, MO; Thierry Alcindor, McGill University Health Centre, Montreal, Quebec, Canada; Robin L. Jones, The Royal Marsden Hospital, Institute of Cancer Research, London, United Kingdom; David R. D'Adamo and Matthew Guo, Eisai, Woodcliff Lake, NJ; and Sant Chawla, Sarcoma Oncology Center, Santa Monica, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.6605DOI Listing
October 2017

Intensity of recent years in the investigation of soft tissue sarcoma.

Authors:
Jean-Yves Blay

Future Oncol 2017 Jun 2;13(13s):3-9. Epub 2017 May 2.

Department of Medical Oncology, Centre Leon Berard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0119DOI Listing
June 2017

Review of past and present clinical cases with a view to future treatment options.

Future Oncol 2017 Jun 2;13(13s):11-28. Epub 2017 May 2.

Department of Medical Oncology, Centre Leon Berard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0120DOI Listing
June 2017

Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.

J Clin Oncol 2017 May 31;35(15):1713-1720. Epub 2017 Mar 31.

Paolo G. Casali, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori and University of Milan; Elena Fumagalli and Alessandro Gronchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milano, Italy; John Zalcberg, Peter MacCallum Cancer Institute, East Melbourne, Victoria; Dusan Kotasek, Adelaide Cancer Centre, Kurralta Park and University of Adelaide, South Australia, Australia; Axel Le Cesne, Gustave Roussy, Villejuif; Jean-Yves Blay, NetSARC and Site de Recherche Intégrée sur le Cancer de Lyon, Centre Leon Berard, Lyon; Antoine Italiano, Institut Bergonie, Bordeaux, France; Peter Reichardt, HELIOS Klinikum Berlin-Buch, Berlin; Lars H. Lindner, Klinikum der Universitaet München, München; Viktor Grünwald, School Hannover, Hannover, Germany; Ian R. Judson and Winette van der Graaf, Royal Marsden Hospital, London, United Kingdom; Patrick Schöffski, Universitaire Ziekenhuizen Leuven, Campus Gasthuisberg, Leuven; Saskia Litière and Sandrine Marreaud, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Serge Leyvraz, University Hospital, Lausanne, Switzerland; Antonio Lopez Pousa, Hospital De La Santa Creu I Sant Pau, Barcelona, Spain; Stefan Sleijfer and Jaap Verweij, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam; Jan M. Kerst, The Netherlands Cancer Institute, Amsterdam; Pancras Hogendoorn, Leiden University Medical Center, Leiden; Winette van der Graaf, Radboud University, Medical Center Nijmegen, the Netherlands; and Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.0228
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.0228DOI Listing
May 2017

Giant cell tumour of bone in the denosumab era.

Eur J Cancer 2017 05 30;77:75-83. Epub 2017 Mar 30.

Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.02.021DOI Listing
May 2017

Improving treatment results with reference centres for rare cancers: where do we stand?

Eur J Cancer 2017 05 3;77:90-98. Epub 2017 Apr 3.

GSF-GETO/NETSARC, Centre Léon Bérard & Université Claude Bernard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.02.006DOI Listing
May 2017

[Cancer screening in France: 10 years of analysis of behaviours by the EDIFICE surveys].

Bull Cancer 2017 Mar 18;104(3):258-266. Epub 2017 Jan 18.

CHRU de Tours, centre de coordination des dépistages des cancers, 37044 Tours cedex 9, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.12.002DOI Listing
March 2017

PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.

Oncoimmunology 2017 8;6(3):e1278100. Epub 2017 Feb 8.

Department of Molecular Oncology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, UMR1068 Inserm , Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1278100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384364PMC
February 2017